Impact of phytoestrogen use on the quality of life of perimenopausal or postmenopausal women in Sinaloa, Mexico
DOI:
https://doi.org/10.56294/saludcyt20251095Keywords:
Phytoestrogens, Quality of Life, Perimenopause, Postmenopause, Hormone Replacement TherapyAbstract
Introduction: menopause causes clinical symptoms that significantly impact women’s quality of life. Phytoestrogens, such as soy isoflavones, have been studied as treatment for climacteric syndrome, showing improvements in vasomotor and psychological symptoms.
Objective: to determine the impact of the use of phytoestrogens (soy isoflavones) on the quality of life of women with perimenopause or postmenopause at Family Medicine Unit No. 55 of the Mexican Social Security Institute in Culiacán, Sinaloa, Mexico. Method: a randomized clinical trial was conducted with 44 women aged 45 to 60 with climacteric symptoms. Participants were assigned to an experimental group (EG), which received 50 mg of soy isoflavones every 24 hours, and a control group (CG), which received a placebo for 12 weeks. The Menopause Rating Scale was applied before and after the intervention to evaluate somatic, psychological, and urogenital symptoms. Descriptive and inferential statistics were used. Results: supplementation with soy isoflavones in the EG showed significant improvements in overall quality of life (Cohen d = 1,54), as well as in the somatic (d = 1,52) and psychological (d = 1,10) subscales, indicating a large effect (d > 0,80). However, the urogenital dimension showed no significant effect (d = 0). The CG experienced a significant deterioration in these subscales. Conclusions: soy isoflavones significantly improved the quality of life of women in perimenopause and postmenopause in the somatic and psychological dimensions, showing a large effect. No changes were observed in the urogenital dimension
References
1. Organización Panamericana de la Salud. OPS/OMS México participa en el Foro “La menopausia: un desafío de política pública” [Internet]. Washington, DC; Organización Panamericana de la Salud; 2023 [citado 16 sept 2024]. Disponible en: https://www.paho.org/es/noticias/17-5-2023-opsoms-mexico-participa-foro-menopausia-desafio-politica-publica
2. Khapre S, Deshmukh U, Jain S. The impact of soy isoflavone supplementation on the menopausal symptoms in perimenopausal and postmenopausal women. J Mid-life Health [Intermet]. 2022 [citado 16 sept 2024];13:175-184. Disponible en: http://dx.doi.org/10.4103/jmh.jmh_190_21
3. Ahsan M, Khurram Mallick A. The Effect of Soy Isoflavones on the Menopause Rating Scale Scoring in Perimenopausal and Postmenopausal Women: A Pilot Study. J Clin Diag Res [Internet]. 2017 [citado 16 sept 2024];11(9):13-16. Disponible en: http://dx.doi.org/10.7860/jcdr/2017/26034.10654
4. Tranche S, Brotons C, Pascual de la Pisa B, Macías R, Hevia E, Marzo-Castillejo M. Impact of a soy drink on climacteric symptoms: an open-label, crossover,randomized clinical trial. Gynecol Endocrinol [Internet]. 2016 [citado 16 sept 2024];32(6):477–482. Disponible en: http://dx.doi.org/10.3109/09513590.2015.1132305
5. Tandrup Lambert MN, Thorup AC, Szoscka Hansen ES, Jeppesen PB. Combined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms. PLOS ONE [Internet].2017 [citado 16 sept 2024];12(6):e0176590. Disponible en: http://dx.doi.org/10.1371/journal.pone.0176590
6. Carmignani LO, Orcesi Pedro A, Costa-Paiva LH, Pinto-Neto AM. The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: A randomized controlled trial. Maturitas [Internet]. 2010 [citado 16 sept 2024];67(3):262–269. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0378512210002835
7. Carmignani LO, Orcesi Pedro A, Montemor EB, Arias VA, Costa-Paiva LH, Pinto-Neto AM. Effects of a soy-based dietary supplement compared with low-dose hormone therapy on the urogenital system: A randomized, double-blind, controlled clinical trial. Menopause [Internet]. 2015 [citado 16 sept 2024];22(7):741–749. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25423326/
8. Barnard N, Kahleova H, Holtz D, Znayenko-Miller T, Sutton M, Holubkov R, Zhao X, Galandi S, Setchell K. A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial. Menopause [Internet]. 2023 [citado 16 sept 2024];30(1): 80-87. Disponible en:https://journals.lww.com/menopausejournal/fulltext/2023/01000/a_dietary_intervention_for_vasomotor_symptoms_of.12.aspx
9. Ehsanpour S, Salehi K, Zolfaghari B, Bakhtiari S. The effects of red clover on quality of life in post-menopausal women. Iranian Journal of Nursing and Midwifery Research [Internet]. 2012 [citado 16 sept 2024];17(1):34. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590693/
10. Rattanatantikul T, Maiprasert M, Sugkraroek P, Bumrungpert A. Efficacy and safety of nutraceutical on menopausal symptoms in post-menopausal women: A randomized, double-blind, placebo-controlled clinical trial. J Diet Suppl [Internet]. 2022 [citado 16 sept 2024];19(2):168–183. Disponible en: http://dx.doi.org/10.1080/19390211.2020.1853648
11. Kim HI, Kim MK, Lee I, Yun J, Kim EH, Seo SK. Efficacy and safety of a standardized soy and hop extract on menopausal symptoms: A 12-week, multicenter, randomized, double-blind, placebo-controlled clinical trial. J Altern Complement Med [Internet]. 2021 [citado 16 sept 2024];27(11):959–967. Disponible en: http://dx.doi.org/10.1089/acm.2021.0027
12. Martínez-Esquivel R, García-Aguilar N, González-Martell A, Cilia-López V. Beneficios del consumo de alimentos con fitoestrógenos durante el climaterio. Enferm. univ. [Internet]. 2021 [citado 16 de septiembre de 2024];18(4):514-524. Disponible en: https://doi.org/10.22201/eneo.23958421e.2021.4.858
13. Bailón-Uriza R, Ayala-Méndez JA, Celis-González C, Chávez-Brambila J, Hernández-Marín I, Maldonado-Alvarado JD, Montoya-Cossío J, Molina-Segui F, May-Hau A, Riobó-Serván P, Neri-Ruz E, Peralta-Sánchez A, Reyes E, Rosado-López R, Santa Rita-Escamilla TT, Tena-Alavez G, Laviada-Molina H. Bebidas de soja y salud femenina. Revisión de la evidencia y opinión de expertos. Nutr Hosp [Internet]. 2023 [citado 16 sept 2024];40(5):1056-1067. Disponible en: https://dx.doi.org/10.20960/nh.04372
14. McKenzie JE, Pagea J, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D, Yepes-Nuñez JJ, Urrútia G, Romero-García M, Alonso-Fernández S. Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas. Rev Esp Cardiol [Internet]. 2021 [citado 16 sept 2024];74(9): 790-799. Disponible en: https://doi.org/10.1016/j.recesp.2021.06.016
15. Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). HRQOL [Internet]. 2003 [citado 16 sept 2024];1(28):1-4. Disponible en: https://doi.org/10.1186/1477-7525-1-28
16. López Salas RG, Chacón Pizano WL. Sintomatología más frecuente en mujeres durante su climaterio mediante la menopause rating scale. Psicología Iztacala [Internet]. 2021 [citado 16 sept 2024];24(3):1277-1290. Disponible en: https://www.revistas.unam.mx/index.php/repi/article/view/80676
17. Norma Oficial Mexicana NOM-012-SSA3-2012, para la ejecución de proyectos de investigación para la salud en seres humanos [Internet]. México: Diario Oficial de la Federación; 2013. [citado 15 Sep 2024]. Disponible en: https://dof.gob.mx/nota_detalle.php?codigo=5284148&fecha=04/01/2013#gsc.tab=0
18. Ley General de Salud. Nueva Ley publicada en el Diario Oficial de la Federación [Internet]. México: DOF; 2024. [citado 15 Sep 2024]. Disponible en: https://www.diputados.gob.mx/LeyesBiblio/pdf/LGS.pdf
19. Reglamento de la Ley General de Salud en Materia de Investigación para la Salud. [Internet]. México: DOF; 2014. [citado 19 Sep 2024]. Disponible en: https://www.diputados.gob.mx/LeyesBiblio/regley/Reg_LGS_MIS.pdf
20. Candia Plata MC, Leverda González DJ, Pacheco Quiroz M, Vázquez Medina OH, Álvarez Hernández G, López Soto LF. Bases jurídicas, normativas y éticas de la investigación en seres humanos, en México. BIOTECNIA [Internet]. 2024. [citado 15 Sep 2024]; 26:233-240. Disponible en: https://biotecnia.unison.mx/index.php/biotecnia/article/view/2252
21. Asociación Médica Mundial. Declaración de Helsinki de la AMM – Principios éticos para las investigaciones médicas en seres humanos [Internet]. Francia/AMM; 2015 [citado 15 Sep 2024]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/
22. Comisión Nacional de Bioética. Informe de Belmont. Principios y guías éticos para la protección de los sujetos humanos de investigación [Internet]. México: CONBIOÉTICA; 2003. [citado 15 Sep 2024]. Disponible en: https://www.conbioetica-mexico.salud.gob.mx/descargas/pdf/normatividad/normatinternacional/10._INTL_Informe_Belmont.pdf
23. Organización Panamericana de la Salud y Consejo de Organizaciones Internacionales de las Ciencias Médica. Pautas éticas internacionales para la investigación relacionada con la salud con seres humanos, Cuarta Edición. Ginebra: CIOMS; 2016. [citado 15 Sep 2024] Disponible en: https://cioms.ch/wp-content/uploads/2017/12/CIOMS-EthicalGuideline_SP_INTERIOR-FINAL.pdf
24. López-Ríos L, Barber MA, Wiebe J, Machín RP, Vega-Morales T, Chirino R. Influence of a new botanical combination on quality of life in menopausal Spanish women: Results of a randomized, placebo-controlled pilot study. PLOS ONE [Internet]. 2021 [citado 16 sept 2024];16(7):e0255015. Disponible en: http://dx.doi.org/10.1371/journal.pone.0255015
25. SSteinberg FM, Murray MJ, Lewis RD, Cramer MA, Amato P, Young RL, Barnes S, Konzelmann KL, Fischer JG, Ellis KJ, Shypailo RJ, Fraley JK, Smith EOB, Wong WW. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. Am J Clin Nutr [Internet]. 2011 [citado el 16 sept 2024];93(2):356–367. Disponible en: http://dx.doi.org/10.3945/ajcn.110.008359
26. Nikander E, Rutanen EM, Nieminen P, Wahlström T, Ylikorkala O, Tiitinen A. Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women. Fertility and Sterility [Internet]. 2005 [citado el 16 sept 2024];83(1):137–142. Disponible en: http://dx.doi.org/10.1016/j.fertnstert.2004.09.003
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Irene Estefanye Jimenez Leyva, Nava Castañeda María de los Angeles, Gabriela del Carmen Angulo Trizón, Julio Manuel Medina Serrano, Maria Elena Aguilar Lizarraga, Diana Cristina Navarro Rodríguez, Kimberly Estefanía Dorantes Bernal, Dulce Samantha Ortíz Fonseca, Roberto Joel Tirado Reyes, Hermilia Páez Gámez (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
